|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7000 MYR | 0.00% |
|
+1.45% | +1.45% |
| Market Cap | 155M 37.92M 33.14M 30.58M 28.19M 53.12M 3.65B 54.3M 365M 144M 1.79B 142M 139M 6.16B | P/E 2026 * |
9.94x | P/E 2027 * | 9.41x |
|---|---|---|---|---|---|
| Enterprise Value | 155M 37.92M 33.14M 30.58M 28.19M 53.12M 3.65B 54.3M 365M 144M 1.79B 142M 139M 6.16B | EV / Sales 2026 * |
0.64x | EV / Sales 2027 * | 0.59x |
| Free-Float |
14.34% | Yield 2026 * |
3.57% | Yield 2027 * | 3.86% |
| 1 week | +1.45% | ||
| Current month | +4.48% | ||
| 1 month | +3.70% | ||
| 3 months | +2.94% | ||
| 6 months | +2.94% | ||
| Current year | +1.45% |
| 1 week | 0.68 | 0.7 | |
| 1 month | 0.64 | 0.7 | |
| Current year | 0.62 | 0.72 | |
| 1 year | 0.62 | 0.74 | |
| 3 years | 0.58 | 0.8 | |
| 5 years | 0.58 | 0.8 | |
| 10 years | 0.57 | 1.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ban Keong Lim
CEO | Chief Executive Officer | 55 | 2015-03-31 |
Yan San Chan
DFI | Director of Finance/CFO | 56 | 2013-12-31 |
| Chief Operating Officer | 38 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 2015-03-31 | |
Ban Keong Lim
BRD | Director/Board Member | 55 | 2015-03-31 |
Kam Weng Foong
BRD | Director/Board Member | 66 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/31/25 | Buy | Chief Executive Officer | 110,000 | 0.0497% | ||
| 9/22/23 | Buy | Chief Executive Officer | 17,000 | 0.0077% | ||
| 9/8/23 | Buy | Chief Executive Officer | 103,000 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +1.45% | +13.82% | -3.45% | 37.92M | ||
| +0.85% | -0.80% | +54.84% | +163.70% | 1,051B | ||
| +1.23% | -1.53% | +55.26% | +59.07% | 609B | ||
| +0.04% | +2.58% | +32.96% | +88.75% | 450B | ||
| +0.78% | -0.71% | +30.04% | +24.61% | 330B | ||
| +1.41% | +0.58% | +33.92% | +47.20% | 284B | ||
| -0.27% | -1.87% | +22.13% | +23.47% | 263B | ||
| -1.76% | +2.37% | -22.19% | -38.45% | 223B | ||
| -1.42% | +0.80% | +22.81% | +60.77% | 198B | ||
| -1.48% | +3.43% | +23.42% | +73.31% | 167B | ||
| Average | -0.11% | +0.63% | +26.70% | +49.90% | 357.51B | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 244M 59.48M 51.98M 47.96M 44.21M 83.33M 5.73B 85.18M 573M 225M 2.81B 223M 218M 9.66B | 265M 64.78M 56.61M 52.24M 48.15M 90.75M 6.24B 92.76M 624M 246M 3.06B 243M 238M 10.52B |
| Net income | 15.6M 3.81M 3.33M 3.07M 2.83M 5.34M 367M 5.45M 36.71M 14.44M 180M 14.3M 13.99M 618M | 15.6M 3.81M 3.33M 3.07M 2.83M 5.34M 367M 5.45M 36.71M 14.44M 180M 14.3M 13.99M 618M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | MYR 0.7000 | 0.00% | 66,000 |
| 26-07-14 | MYR 0.7000 | +1.45% | 130,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 5278 Stock
Select your edition
All financial news and data tailored to specific country editions
















